![p cad 2014 p cad 2014](https://www.mdpi.com/ijerph/ijerph-18-01773/article_deploy/html/images/ijerph-18-01773-g002.png)
![p cad 2014 p cad 2014](https://www.jacc.org/cms/asset/f0aea7b0-0322-44d2-8c9f-6ae2590367bd/s0735-1097(14)61847-7.fp.png)
![p cad 2014 p cad 2014](https://www.frontiersin.org/files/Articles/582865/fcvm-07-582865-HTML/image_m/fcvm-07-582865-g004.jpg)
Aspirin therapy should almost always be continued indefinitely in patients with CAD.
#P CAD 2014 UPDATE#
The scope of this focused update is limited to addressing recommendations on duration of DAPT (aspirin plus a P2Y 12 inhibitor) in patients with coronary artery disease (CAD).The following are key points to remember about the updated guideline on duration of dual antiplatelet therapy (DAPT) in patients with coronary artery disease (CAD):